Russian pharmaceutical and medical industry companies can be subsidized for partial reimbursement

Russian pharmaceutical and medical industry companies can be subsidized for partial reimbursement. Such a support measure is implemented within the state program of the Russian Federation «Development of the pharmaceutical and medical industry» for 2013-2020. The state aid measures are aimed at stimulating investment activities of Russian manufacturers to create, expand and revamp their facilities.

A list of projects subject to subsidies granting to pharmaceutical and medical industry companies is as follows:

• organization and carrying-out of clinical trials of medicinal drugs (see details at https://gisp.gov.ru/support-measures/list/6616939/);
• organization of manufacture of medicinal drugs and (or) pharmaceutical ingredients (see details at https://gisp.gov.ru/support-measures/list/6616940/);
• development of improved equivalents for innovative medicinal drugs (see details at https://gisp.gov.ru/support-measures/list/6987532/);
• organization and carrying-out of clinical trials of implantable medical devices (see details at https://gisp.gov.ru/support-measures/list/6616912/);
• organization of manufacture of medical devices (see details at https://gisp.gov.ru/support-measures/list/6616913/);